Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000950170-24-019463

Chief Business Officer acquired 37,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Savill Corrine Chief Business Officer 2024-02-22 Grant or award +37,500 203,490 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Savill Corrine Chief Business Officer 2024-02-22 Grant or award · Stock Option (Right to Buy) +75,000 75,000 D: show line 2 in the form
Loading xslF345X05/ownership.xml…